WASHINGTON (AP) — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients.
Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least temporarily, researchers reported Wednesday.
So-called CAR-T therapy already is used to fight blood-related cancers like leukemia but researchers have struggled to make it work for solid tumors. Now separate teams at Massachusetts General Hospital and the University of Pennsylvania are developing next-generation CAR-T versions designed to get past some of glioblastoma’s defenses.
“It’s very early days,” cautioned Penn’s Dr. Stephen Bagley, who led one of the studies. But “we’re optimistic that we’ve got something to build on here, a real foundation.”
Related articles:
Related suggestion:
Avalanche goalie Alexandar Georgiev hoping confidence boost carries into Game 3 against JetsMiller retires Judge to finish first 4Georgia tabs Cecile Landi, Simone Biles' longtime coach, as coBrent Burns, Dmitry Orlov help Hurricanes hold on to beat Islanders 3Chiefs trade up with Bills to select WR Xavier Worthy at No. 28 in NFL draftMeet the members of a transitional council tasked with choosing new leaders for beleaguered HaitiDavid Bowie was rightCowboys get Oklahoma offensive lineman Tyler Guyton after trading down in NFL draftWoman dies after being pulled from river as police arrest man in his 40s 'known to her'Colts take first defensive player of NFL draft, UCLA edge rusher Laiatu Latu at No. 15
2.1342s , 5487.0625 kb
Copyright © 2024 Powered by New strategy to attack aggressive brain cancer shows promise ,Culture Channel news portal